USA flag logo/image

An Official Website of the United States Government

Development of Ultrasound-facilitated Formalin-fixed and Paraffin-embedded…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
80689
Program Year/Program:
2009 / SBIR
Agency Tracking Number:
CA115041
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIO-QUICK CORPORATION
BIO-QUICK CORPORATION 12503 MONTCLAIR DR SILVER SPRING, MD -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2009
Title: Development of Ultrasound-facilitated Formalin-fixed and Paraffin-embedded Tissue
Agency: HHS
Contract: 2R44CA115041-02
Award Amount: $750,000.00
 

Abstract:

DESCRIPTION (provided by applicant): Ultrasound (US) facilitated formalin-fixed and paraffin-embedded (FFPE) tissue specimen preparation technology (US-FFPE) is developed from the widely accepted FFPE technology by introducing ultrasound in every step of t he process. The US-FFPE does not change the gold standard FFPE tissue morphology. However, it greatly reduces tissue specimen preparation time. The whole procedure of FFPE tissue specimen preparation is reduced from 16-48 hr to 20-60 min. The final diagnos is of cancers can be produced in a few hours after surgery or biopsy instead of a few days. This increase of turnaround rate will considerably save patient care costs and greatly relieve patients' psychological burdens in waiting for results. Besides accel erating reagent penetration into tissues, the US-FFPE technology changes the mechanism of biomolecule modification and cross-linking caused by formalin fixation. Biomolecules are much more accessible for detection and extraction. The fact that tissue speci mens are frozen in time at the point of US-FFPE fixation can greatly improve the integrity of biomolecules in tissue specimens, especially for mRNA and phosphoproteins. The Phase I of this project is highly successful. We have constructed a prototype US- FFPE device with continuous-flow and multi-sample capacity. Morphological and molecular biology assay results on tissue specimens produced by the prototype US-FFPE device were highly comparable or even superior to those on tissue specimens produced by the conventional FFPE method. Our goal of the Phase II project is to construct a prototype US-FFPE device that can be applied in clinical tissue specimen preparation to produce standardized tissue specimens at much increased turnaround rate. Different from the conventional FFPE method, the US-FFPE method relies on US to increase speed. With much shortened sample processing time, strict control of the machine performance parameters is critical. Under Phase II, we will develop a highly reliable US-FFPE device wit h real-time quality control and quality assurance (QC/QA) system. The Phase II objectives are: 1) to improve the prototype Phase I US-FFPE device by optimizing the existing functions to achieve high device reliability as well as by addition of new function s to achieve QC/QA; 2) to perform systemic morphological and molecular studies with various tissue types to validate the device and to collect optimal machine operating parameters.

Principal Investigator:

Nianxiang Zou

Business Contact:

Pamala Xu
chu@bio-quick.com
Small Business Information at Submission:

BIO-QUICK CORPORATION
BIO-QUICK CORPORATION 12503 MONTCLAIR DR SILVER SPRING, MD -

EIN/Tax ID: 152218494
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No